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Abstract: This review summarizes recent knowledge about the use of the amino acid L-Cysteine
(L-Cys) through diet, nutritional supplements or drugs with the aim to improve human health or
treat certain diseases. Three databases (PubMed, Scopus, and Web of Science) and different keywords
have been used to create a database of documents published between 1950 and 2017 in scientific
journals in English or Spanish. A total of 60,885 primary publications were ultimately selected to
compile accurate information about the use of L-Cys in medicine and nutritional therapies and to
identify the reported benefits of L-Cys on human health. The number of publications about the use of
L-Cys for these purposes has increased significantly during the last two decades. This increase seems
to be closely related to the rise of nutraceutical industries and personalized medicine. The main
evidence reporting benefits of L-Cys usage is summarized. However, the lack of accurate information
and studies based on clinical trials hampers consensus among authors. Thus, the debate about the
role and effectiveness of supplements/drugs containing L-Cys is still open.
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1. Introduction
L-cysteine (L-Cys) is a non-essential amino acid and thus is one of the building blocks required
for the synthesis of proteins. It contains sulfur in the form of a thiol group (-SH) at the end of its
side chain [1] (Figure 1). The -SH group is responsible for the high reactive capacity of the amino
acid, and therefore is responsible for many of its biological functions in human beings. L-Cys is the
amino acid establishing disulfide bridges, a type of covalent bond that plays a fundamental role
in the folding and stabilization of the tertiary structure of the proteins, thereby supporting their
biological activities [2,3]. The presence of conserved Cys in protein motifs found in all organisms could
indicate that this feature was harnessed in early evolution to support enzyme catalysis, transcriptional
regulation, protein folding, and 3-dimensional structure [4,5].
Cys is synthesized from methionine (an essential amino acid) thanks to two chemical reactions [3].
The first of these reactions is a transmethylation reaction, from which homocysteine is obtained as
product. Then, homocysteine is transformed into cysteine through a transsulfuration reaction [1,6].
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Figure 1. Chemical structure (a) and structural model (b) of an L-cysteine molecule (adapted from [1]). 
Cysteine can be assimilated through different pathways depending on the needs of the cells, 
giving rise to sulfur compounds [6,7]. The main metabolite obtained by the assimilation of Cys is 
sulfinate, a molecule that is metabolized to give rise to sulfinylpyruvate and pyruvate, or hipotaurine 
and taurine (Figure 2). On the one hand, taurine is a fairly abundant molecule at the intracellular 
level. Although the biological role of taurine is not at all clear, some studies suggest that it may be a 
compound involved in the nervous system, being especially necessary for brain development [8]. 
This suggestion is supported by the fact that high levels of taurine have been found in the fetal brain 
[9]. In addition, taurine displays many other biological roles, such as the marking of certain toxic 
intermediaries or the regulation of intracellular calcium levels. On the other hand, the 
sulfinylpyruvate produced during metabolism of Cys may undergo oxidation to sulfate, which is 
later used in the synthesis of 3′-phosphoadenosine-5′-phosphosulfate. There are many other 
important reactions occurring during the metabolism of Cys that allow the synthesis of thiocysteine 
or the transfer of sulfur between molecules [1]. 
 
Figure 2. Summary of cysteine metabolism [8]. 
The human genome encodes about 214,000 Cys-coding sequences [4]. Thus, the presence of this 
amino acid in proteins is significant. The reactivity and diverse functions of Cys are mirrored by a 
spectrum of susceptibilities and dysfunctions of their respective proteins, resulting in central roles 
for the Cys proteome in development, signal transduction, biologic defenses, aging, and disease 
[4,5,10]. Due to these important implications, L-Cys has attracted much attention of medical 
researchers and professionals worldwide (mainly in the USA and Europe). 
Over the past few years, important biological functions of L-Cys in human beings have been 
described for the first time [4–6,11,12]. At the same time, the potential applications of this compound 
at the industrial level have been increasing, mainly in fields related to pharmaceuticals, medicines, 
and nutraceuticals. As examples of these applications, L-Cys plays an important role in the food 
industry (it is used as flavoring or as a chelating agent) [13], pharmaceutical industry (it is part of 
several drug formulas, for instance in drugs used to reduce the levels of acetaldehyde in the oral 
cavity) [14] and the cosmetics industry (L-Cys as part of skin or hair care formulas) [15,16]. 
Figure 1. Chemical structure (a) and structural odel (b) of an L-cysteine molecule (adapted from [1]).
Cysteine can be assimilated through different pathways depending on the needs of the cells,
giving rise to sulfur compounds [6,7]. The main metabolite obtained by the assimilation of Cys is
sulfinate, a molecule that is metabolized to give rise to sulfinylpyruvate and pyruvate, or hipotaurine
and taurine (Figure 2). On the on hand, tauri e is fairly abundant molecule at he intracellular
level. Although the biological role of taurine is ot at all c ear, some studies sugg st that it may be
a compound involved in the nervous system, being especially necessary for brain development [8].
This suggestion is supported by the fact that high levels of taurine have been found in the fetal
brain [9]. In addition, taurine displays many other biological roles, such as the marking of certain toxic
intermediaries or the regulation of intracellular calcium levels. On the other hand, the sulfinylpyruvate
produced during metabolism of Cys may undergo oxidation to sulfate, which is later used in the
synthesis of 3′-phosphoadenosine-5′-phosphosulfate. There are many other important reactions
occurring during the metabolism of Cys that allow the synthesis of thiocysteine or the transfer of sulfur
between molecules [1].
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Figure 2. Summary of cysteine metabolism [8].
The human genome encodes about 214,000 Cys-coding sequences [4]. Thus, the presence of this
amino acid in proteins is significant. The reactivity and diverse functions of Cys are mirrored by a
spectrum of su ceptibilities and dysfunc ions of heir respective proteins, resulting in central roles for
the Cys prot om in dev lopment, signal transduction, b logic defenses, agi g, a d disease [4,5,10].
Due to thes important implications, L-Cys has attracted much attention of medical researchers and
professionals worldwide (mainly in the USA and Europe).
Over the past few years, important biological functions of L-Cys in human beings have been
described for the first time [4–6,11,12]. At the same time, the potential applications of this compound
at the industrial level have been increasing, mainly in fields related to pharmaceuticals, medicines,
and nutraceuticals. As examples of these applications, L-Cys plays an important role in the food
industry (it is used as flavoring or as a chelating agent) [13], pharmaceutical industry (it is part of
several drug formulas, for instance in drugs used to reduce the levels of acetaldehyde in the oral
cavity) [14] and the cosmetics industry (L-Cys as part of skin or hair care formulas) [15,16].
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Medicines and pharmaceuticals based on natural products are currently in an important period
of expansion worldwide. Not only patients but also professionals in medicines, pharmaceuticals,
and cosmetics look for new formulas and less aggressive therapies, in many cases integrating
compounds/drugs of biological origin [17]. Thus, “personalized medicine”, based on drugs of natural
origin as well as clinical nutrition, has experienced a boom in Western countries during the last few
decades [17]. Besides, advances in biotechnology have promoted the design of a huge number of drugs
and supplements for the prevention and the treatment of various diseases [17,18].
L-Cys is a compound widely used in the development of numerous drugs so far. However, the number
of clinical trials testing the effects of L-Cys on human health and wellness is currently scarce. So, the impact
of L-Cys usage (as part of drugs or as dietary supplements) on human health is a controversial issue.
This original work is based on a systematic review of the scientific studies published on L-Cys
using different quality criteria to select the accurate and useful information [19]. The analysis presented
here sheds light on the role and potential positive effects of its use in the prevention and treatment of
diseases, as well as in the improvement and maintenance of health status.
2. Objectives
The main objective is to carry out an exhaustive, accurate, and rigorous analysis of the
information available in scientific databases to identify the effects of the usage of L-Cys in human
health. The analysis considers the use/administration of L-Cys as part of the formulations of drugs,
nutraceuticals, or through food supplementation. This objective can be divided into two sub-objectives:
(1) To compile information about the use of L-Cys in medicines and nutritional therapies (including
clinical trials); (2) To identify the benefits reported by L-Cys on human health.
3. Results
3.1. Compilation of Bibliographic Sources of Interest
After a general search through Google Scholar, the major search engines PubMed, Scopus, and Web
of Science were used to compile information about L-Cys available up to December 2017. This search
indicated that the number of original papers identified through PubMed was significantly higher than
the other two databases mentioned. Consequently, PubMed was the database ultimately chosen to
identify and select the documents of interest for this systematic review. A total of 126,919 studies were
thereby identified using the keyword “L-cysteine” (122,195 of them in English).
The analysis of the documents reveals that the earliest publications focusing on L-Cys can be
traced back to the first third of the 20th century. Nevertheless, the number of scientific publications
concerning L-Cys has mainly increased during the last four decades (Figure 3).
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In total, 92% of the identified studies were descriptions of the physico-chemical properties
of L-Cys or its biological roles. From the total, 8304 (6.54%) studies correspond to systematic
reviews and 1638 (1.29%) are clinical trials. A total of 60,885 primary publications (47.97% of the
total identified) were ultimately selected to comprise the database used in this research. These publications
were selected considering the selection and exclusion criteria indicated in the materials and methods
section, and combining the previous keyword (L-cysteine) with other terms of interest for this study
(“L-cysteine & human health”; “L-cysteine & pharmacology”; “L-cysteine & food processing”; “L-cysteine
& nutritional therapy”; “L-cysteine & nutrition”) (Table 1).
Table 1. Number of publications included in the database for this work (Database: PubMed).
* %: calculated over the total number of publications compiled from each combination of keywords.
Keywords Total of Publications Publications in the Last 5 Years (%)*
L-cysteine & pharmacology 52,873 9976 (19%)
L-cysteine & human health 4742 1725 (36%)
L-cysteine & nutrition 1891 579 (31%)
L-cysteine & nutritional therapy 1074 265 (25%)
L-cysteine & food processing 305 127 (42%)
3.2. Bibliometric and Bibliographic Analysis
The increasing interest worldwide for natural compounds and their application in medicines,
cosmetics, pharmaceuticals, and nutrition has impacted L-Cys research too. As an example, it is
important to highlight that the number of papers reporting positive results from the usage of L-Cys in
medicines and nutritional therapies has significantly increased during the last decade. As is displayed
in Table 1, the United States and United Kingdom are the main countries from which the selected
contributions originate (about 30% each), followed by Japan. Italy, France, and Spain are the European
countries with the highest number of studies in this field at the time of writing this manuscript.
The bibliometric analysis of the selected information states that the greatest number of
scientific–technical publications were within the field of pharmacology (52,873) (Table 1). It is very
striking that, despite the great scientific and technical production on L-Cys and its potential uses,
there is no author/institution and/or journal that significantly highlights the topic. Therefore, it could
be concluded that it is a topic of great interest analyzed from very different perspectives and for
multiple applications.
The increase in the number of publications about L-Cys during the last two decades is meaningful
and relevant (Figure 3). To understand it, some reflections must be made about the recent boom in
“personalized medicine” globally as well as about nutritional habits in developed countries. Interest in
personalized medicine increased significantly between the end of the 20th century and the beginning of
the 21st century as a result of [19]: (i) a great discontent with traditional treatments in certain segments
of the population (some traditional treatments in occidental and oriental medicine are unable to cure
or relieve symptoms in many cases); (ii) personalized treatments being highly demanded in developed
countries; and (iii) the rejection of the population regarding chemically synthesized drugs becoming
significant. In addition, the recognition of nutrition as a key factor for maintaining and restoring health
has also contributed to the general interest for compounds of natural origin in general, and for L-Cys
and other amino acids in particular.
3.3. Review of Clinical Trials on Effects of
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glycine. To make the reading of this work more understandable, the benefits of the usage of L-Cys in
human beings have been summarized and classified into two tables as follows: Table 2 summarizes
the main effects of the usage of L-Cys (alone) on human beings; Table 3 displays the benefits of its
usage for human beings when the amino acid is combined with other molecules such as vitamin D or
glycine. Comments on negative effects of the usage of L-Cys are also summarized after Table 2.
Regarding the use of L-Cys as part of drug formulas or nutritional supplements, the following
benefits have been reported (Table 2): antioxidant power, regulation of the mucolytic function,
strengthening of the hair, improvement of the functions of the immune system, protection and
detoxification of the liver, promotion or elimination of heavy metals, prevention of heart disease,
diabetes prevention, delay of aging, and the protection of the digestive system.
Some studies suggest that there is no clear effect (neither positive nor negative) of L-Cys on human
health whilst some recent works state that L-Cys could behave as a negative modulator on GABAergic
neurotransmission [20].
Table 2. Summary of the potential effects of L-Cys (alone) supported by studies based on clinical trials.
Examples of L-Cysteine Usage Effects Ref.
Nutritional therapy in children with severe edematous malnutrition Restoration of the rate of synthesis and the concentration ofglutathione during the first phase of treatment [21]
Scarring of the cornea after a photoreactive keratectomy Reduced average time of scarring [22]
Nutritional therapy in Ictus patients Reduced risk of cardiovascular accident [23]
Hair care Reduced hair loss and increased hair strengthening abilities [16,24]
Protection of digestive system Reduction in the concentration of acetaldehyde by avoidingexposure in cases of achlorhydria [25]
Treatment chronic inflammation Increased antioxidant status [26]
Prevention of upper digestive tract cancer and breast cancer Decrease of acetaldehyde in saliva or it can be used as part ofmetabolic starvation therapy [27,28]
Indicator for the control of cardiovascular diseases Pro-inflammatory signaling [29]
Treatment of erythropoietic porphyria Photosensitivity improvement [30]
Treatment of type-2 diabetes Control of glycaemia and vascular inflammation [31–33]
Table 3. Summary of the potential effects of L-Cys (combined with other compounds) supported by
studies based on clinical trials.
Composition of the Mixture Examples of Usage Effects Ref.
L-Cysteine + Glycine
Nutritional therapy in elderly HIV + patients Improved oxidation of carbohydrates,insulin sensitivity and body composition [34,35]
Treatment of oxidative stress during aging Increased synthesis of glutathione anddecreases oxidative stress levels
L-Cysteine + glycine +
dithreonine Treatment of hypostatic ulcer
Reduced pain and improved degree of
ulcer healing [36]
L-Cysteine + vitamin D Treatment of patients with type-2 diabetes Increased levels of glutathione anddecreased levels of triglycerides [33]
L-Cysteine + basic fibroblast
growth factor (bFCF)
Treatment of corneal epithelium after
photoreactive keratectomy in patients affected
by myopia
Reduced time of resurfacing corneal. [37]
L-Cysteine + theanine Improvement of well-trained athletes’performance
Restoration of the attenuation of the activity
of Natural Killer cells [38]
Although some prominent clinical trials have tested the effects of L-Cys, most of them have
analyzed the effects of N-acetyl-L-cysteine (NAC) instead [39,40]. This compound (Figure 4) is a
precursor of L-Cys that promotes glutathione biosynthesis [41]. It acts directly as a scavenger of free
radicals, mainly oxygen radicals. Consequently, it is a powerful antioxidant useful for treating several
disorders that result from the generation of free oxygen radicals. Additionally, it is a highly efficient
mucolytic drug promoting tenacious mucous discharges [42]. The main effects of its usage in human
beings are summarized in Table 4.
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Table 4. Summary of the potential effects of NAC supported by studies based on clinical trials.
Examples of usage Effects Ref.
Treatment of methamphetamine-dependent patients Methamphetamine dependence decreases [43]
Performanc of athletes undergoing strenuous physical training Redox equilibrium and daptation processes improve [44]
Treatment of Thalassemia Oxidative stress and DNA damage decrease [45,46]
Protection against the carcinogenic effect of tobacco Modulation of biomarkers associated with cancer [47]
Treatment of bacterial meningitis Antioxidant role [48,49]
Treatment against influenza virus Proliferation of the virus is inhibited [49,50]
Mucolytic expectorant and treatment of respiratory tract infections The viscosity decreases and facilitates the removal of mucus [40,51]
Specific antidote for acetaminophen overdose Regeneration of glutathione levels [49,52–54]
Cardiov scular com lications in patients with diabetes
Treatment of type-2 diabetes Attenuation of cardiovascular complications [55–57]
Prevention of cardiovascular diseases Reduction of pl sma concentrations and homocyst ine levels [58]
Treatment of chronic hepatitis C Increase in glutathione and improvement in response to treatmentwith interferon [59,60]
Treatment of patients with acute liver failure Reduced IL-17 levels [61–64]
Treatment of nephropathic cystinosis Reduced oxidative stress and improved renal function [65]
Treatment of noise-induced hearing loss Protective effect. Hearing loss is reduced [66]
Treatment of cocaine addiction It acts as an anti-relapse agent in abstinent subjects [67,68]
I brief, NAC supplementation has exerted favorable effects on vascular health, muscle trength,
bone density, cell-mediated immunity, pre ervatio of cognitive function, or marking sy temic
inflammation [49,67,69–72]. Although positive effects of NAC have been reported for treatments
of patients with acute liver failure [61], other studies on acute liver failure and liver surgery suggest
patients randomized to postoperative NAC received no benefit [62–64]. Finally, NAC is part of
the paracetamol formula (acetaminophen). When paracetamol is taken in large quantities, a minor
metabolite called N-acetyl-p-benzoquinone imine (NAPQI) accumulates within the body. It is normally
conjugated by glutathione, but when taken in excess, the body’s glutathione reserves are not sufficient
to deactivate the toxic NAPQI. This metabolite is then free to react with key hepatic enzymes, thereby
damaging liver cells. This may lead to severe liver damage and even death by acute liver failure.
This phenomenon is commonly named paracetamol poisoning [73–75].
4. Discussion
The review of all selected documents, and particularly the clinical trials, has enabled identification
of the effects of the usage of L-Cys in human health and wellness, either by its application individually
or combined with o her compounds. The clearly demonstrated benefits on human health are as follows:
- Antioxidant role. L-Cys acts as a precursor for the synthesis of glutathione, which is an
important antioxidant. The reduced form of glutathione plays a fundamental role in the
defense of the organism against damage caused by oxidative stress [76]. This property is due
to its ability to neutralize reactive particles that can cause damage to cells and tissues. Thus,
diet supplementation with L-Cys restores the synthesis of glutathione in cases in which it has
been compromised, thus improving the redox balance and promoting the reduction of oxidative
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stress. In addition, the elimination of free radicals may also be associated with certain benefits,
such as in the case of reduced healing time following certain surgical procedures (photorefractive
keratectomy, for instance) [22]. Besides, the antioxidant role of L-Cys is also related to reduced
risk of a cerebrovascular accident [23] and reduced noise-induced hearing loss [66].
- Mucolytic function. NAC causes a decrease in the viscosity of mucus secretion, thus facilitating
their elimination. Bronchial secretions contain high concentrations of mucoproteins. The decrease
in viscosity promoted by NAC is mainly due to the breakage of the disulfide bonds of the
mucoproteins, resulting in a fragmentation of the chains from the mucins, immunoglobulins and
serum albumin present in the mucous secretion [40].
- Strengthening of hair. Blends fortified with L-Cys help to strengthen hair. Keratin is one of
the most abundant proteins in the skin and the hair, and contains high amounts of L-Cys as
building blocks. L-Cys forms disulfide bridges, which provide strength and rigidity to keratin.
Consequently, the use of blends fortified with L-Cys promotes the repair of structural lesions
and slows down hair loss experienced by patients affected by certain disorders (diffuse alopecia,
for instance [24]).
- Regulation of the activity of the immune system. It has been reported that L-Cys can regulate
immune system activity by promoting changes in levels of production of its effector molecules,
as is the case of IL-17. IL-17 is a cytokine produced mainly by some T-cells, called Th17 cells,
which act on epithelial cells and fibroblasts, as well as on other cells of the immune system. It has
also been demonstrated that the administration of NAC can significantly improve transplant-free
survival in patients affected by acute liver failure not related to acetaminophen when administered
during the early stages of hepatic encephalopathy. This effect is due to the regulation of
IL-17 production, which is closely related to the progression of the encephalopathy [61].
- Protection of the digestive system. Excessive alcohol consumption is considered a risk factor for
the development of cancer in the upper gastrointestinal tract, because of exposure to acetaldehyde,
which is carcinogenic to humans. In this sense, L-Cys intake reduces the concentration of
acetaldehyde in saliva, thus decreasing the exposure of the gastrointestinal tract to this compound
and, consequently, the risk of cancer [27].
- Reducing the risk of stroke. Some studies suggest that consumption of certain amino acids,
among which L-Cys, may be related to certain cardiovascular benefits, such as reduced arterial
stiffness or reduced blood pressure, thereby fighting some risk factors related to vascular accidents
in healthy women [55].
Despite the high volume of evidence describing positive impacts of L-Cys on human health,
it is worth noting that the number of works describing no effects or negative effects is also
significant [20,77,78]. Negative effects of L-Cys derivatives on human health have been reported [79,80].
Thus, although most of the studies on L-Cys highlight its role in the homeostasis of redox status,
some studies suggest that redox modulation is not involved during L-Cys actions and that L-Cys
might act as a competitive antagonist of GABAA ρ1 receptors for instance [20]. Also, some in vivo
studies have shown that several S-conjugates are nephrotoxic and that the toxicity is associated with
β-lyase-dependent bioactivation [79]; in other cases, toxic effects of L-Cys on the nervous system have
also been reported (oxidized L-Cys derivatives or compounds such as cysteine alpha-carbamate caused
neuronal degeneration) [78].
So, the controversy surrounding the benefits of supplements or drugs containing L-Cys is still
open, mainly regarding their use for some specific treatments. In fact, many of the studies have been
done in vitro and translational studies are still scarce. The following considerations can be underlined,
taking into account this controversy and the results obtained from this review:
(i) According to the results analyzed here, NAC is preferentially used instead of L-Cys. Besides,
L-Cys is usually administrated as part of a formula containing other compounds, such as glycine,
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vitamin D, bFCF or theanine. So, the effects reported in these studies cannot be directly attributed
solely to the L-Cys molecule.
(ii) Most of the studies done at the time of writing this review are based on laboratory tests and
cellular lines.
(iii) The number of studies on the effects of L-Cys on human health based on clinical trials is limited
and in many cases these are very preliminary studies in which the studied population does not
reflect a standard population (considering aspects such as age, sex, etc.).
(iv) Several important details related to L-Cys and NAC doses and metabolism remain unknown.
Optimal L-Cys doses and safety concentration ranges according to some pathologies are far from
known. In addition, optimization of the assimilation of L-Cys and its derivatives, when applied
through nutritional supplements, is poorly described.
5. Materials and Methods
5.1. Search Strategy and Information Processing
First, several searches of generic character in the “Google Scholar” portal (https://scholar.google.es/)
were carried out. In this search, several important secondary sources were identified which have been
helpful for the design of this systematic review and for writing the introduction section.
The second step in this work was the realization of a comprehensive bibliometric/bibliographic
review through the major search engines available, PubMed, Scopus, and Web of Science (which are
connected to specialized databases on the subject covered by this study). This search indicated that
the number of original papers identified through PubMed was significantly higher than the other
two databases mentioned. Consequently, PubMed was the database ultimately chosen to identify
and select the documents of interest for this work. The search date was between January 1950 and
December 2017 and included texts published in scientific journals in English and Spanish. The research
questions were as follows: What role does L-cysteine play in pharmacology, human health, nutrition,
and food processing? What is the effect of L-Cys on human health?
The information retrieval system “boolean” was used to identify the works of interest for this
review [81]. The keywords used were as follows: “L-cysteine”; “L-cysteine & human health”; “L-cysteine
& pharmacology”; “L-cysteine & food processing”; “L-cysteine & nutritional therapy”; “L-cysteine &
nutrition”. These keywords were previously identified through the “MeSH” (Medical Subject Heading)
database as descriptors for the realization of this work. The advanced search form was used in the
PubMed database to identify the documents of interest. Additionally, the following options were
selected: “Title/abstract”, “article”, “review”.
At a more advanced stage of the study, special attention was paid to clinical trials (most of them
published over the last 25 years) to identify the main uses and possible effects of L-Cys in its application
within the field of medicine.
5.2. Data Extraction and Selection of Relevant Studies
A total of 126,919 articles were identified but 60,885 were ultimately selected to constitute the
database for this research. The selection criteria were as follows: primary sources, review/original
articles, clinical trials, and studies with objective data on direct correlations between the use of
L-Cys and effects on human health (adults, adolescents, and children). In all the selected studies,
the direct correlations were established when L-Cys was naturally part of the food intake or as part
of nutritional supplements. The exclusion criteria were as follows: articles of non-specific systematic
review, meta-analyses of humans, or other non-human clinical trials with non-representative sample
size. Each of the selected articles has been analyzed by the three authors with backgrounds in biology,
biochemistry and nutrition. The classic scheme proposed by Vilanova has been used to assure the
quality of the selection criteria [19]. Thus, the following questions were considered to evaluate each
of the identified works (quality criteria): is it related to the research objectives of this review? Is the
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methodology clear and objective? Is the study 100% reproducible? Is the sample size coherent? Is the
sample well-defined? Is the sample representative? Is the hypothesis clearly stated?
6. Conclusions
Over the past few years, several benefits have been attributed to L-Cys and NAC, contributing to
their becoming useful compounds within the food, pharmaceuticals, medicines or cosmetics industries.
A considerable number of cysteine-rich products that are mainly used in hair and skin care have been
commercialized. More recently, L-Cys has emerged as an important molecule in the food supplements
industry, a sector that is in full growth, possibly due to increasingly widespread concern in the
populations of developed countries to address nutritional deficiencies caused by new habits of life and
the inability, on certain occasions, to follow a balanced diet. Thus, nutritional therapy and functional
foods have involved L-Cys as part of treatment of several pathologies such as cirrhosis (in which
L-Cys biosynthesis is compromised) [82], or simply to prevent cancer or promote good health [83,84].
Although several potential benefits have been attributed to L-Cys or NAC, only a few of these benefits
have been clearly demonstrated. Some of these examples are (i) the use of these molecules as a
mucolytic expectorant; (ii) positive effects on cirrhosis treatment or positive contributions in the
maintenance of redox homeostasis in cells and in cancer treatment (through GSH synthesis) [85,86].
Another important aspect to point out is the potential use of L-Cys in processes related to food
conservation and processing. L-Cys shows antioxidant, chelating, and flavoring properties which
could be useful in food industries [13,87]. However, few applications of this amino acid are already
available on the market (and only in developed countries).
In summary, although the available literature on L-Cys and NAC is abundant, several key
questions remain unaddressed. Consequently, more effort must be made in the near future to
establish clear and direct connections between these two molecules and benefits on human health.
These connections should be made not only based on in vitro analysis but also based on clinical trials
carried out under quality standards and good practices as has been recently recommended [88,89].
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